Implementation of a standardized pathway for the treatment of cardiac arrest patients using therapeutic hypothermia:

Ryan D Hollenbeck1, Quinn Wells, Jeremy Pollock

  • 1Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Insights

Implementing the CODE ICE pathway significantly reduced the time to initiate therapeutic hypothermia (TH) and reach target temperatures in cardiac arrest survivors. Further studies are needed to assess its impact on clinical outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Neurology

Background:

  • Out-of-hospital cardiac arrest (OHCA) has high mortality, with neurologic injury being a primary cause of death in survivors.
  • Therapeutic hypothermia (TH) is a recommended treatment for comatose cardiac arrest survivors to mitigate neurologic injury.
  • Implementing standardized TH protocols requires a multidisciplinary approach and can be challenging.

Purpose of the Study:

  • To evaluate the impact of a revised institutional protocol, "CODE ICE," on the timeliness of therapeutic hypothermia initiation and target temperature achievement in cardiac arrest patients.
  • To assess the integration of therapeutic hypothermia with regional ST-elevation myocardial infarction networks.

Main Methods:

  • A retrospective analysis of 150 consecutive comatose cardiac arrest victims treated with TH before (n=82) and after (n=68) the CODE ICE implementation (2007-2011).
  • CODE ICE involved a multidisciplinary team, burst paging, computerized physician support, and integration with the STEMI network.

Main Results:

  • The mean time to TH initiation decreased from 306 ± 165 minutes pre-CODE ICE to 196 ± 144 minutes post-CODE ICE (P < 0.001).
  • The mean time to reach target temperature decreased from 532 ± 214 minutes to 392 ± 215 minutes (P < 0.001).
  • No significant changes in survival or neurologic outcome at hospital discharge were observed.

Conclusions:

  • The CODE ICE pathway effectively reduced the time to initiate TH and achieve target temperatures in cardiac arrest survivors.
  • While CODE ICE improved process metrics, further research is necessary to determine its effect on long-term clinical outcomes like survival and neurologic recovery.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...